Slide Background
Defining A New Platform Technology
To transform chronic disease treatment through non-invasive, energy-based technologies that restore the body’s natural balance.
Slide Background
Expanding the Future of Therapeutics
Our current project focuses on obesity treatment. This is just the beginning—our technology opens the door to new applications beyond metabolic health, with future opportunities in cardiovascular, oncology, chronic pain management, gastroenterology, neurology and more.

THE COMPANY

A Medtech venture focused on a platform technology with multi-indication opportunity.
Waveffect is a health technology company developing a novel seismic energy-based medical solution for the non-invasive, drug free treatment of obesity, and beyond.

At the core of our mission is the belief that starting with obesity, chronic diseases can be addressed by working with the body’s own regulatory intelligence rather than against it. United by this vision, our team brings together expertise in mechanical and electronic engineering, artificial intelligence, clinical medicine, regulatory strategy, and preclinical science.

VISION

To pioneer a new era of healthcare where non-invasive technologies restore the body’s natural regulatory systems transforming the treatment of chronic conditions through seismic energy-based medical interventions.

MISSION

Our mission is to develop safe, scalable, and scientifically validated solutions that activate internal receptors through seismic pressure pulses. We aim to establish a breakthrough non-invasive platform technology—empowering patients and clinicians with smarter, drug-free alternatives that work in harmony with human physiology.

THE PEOPLE

A team defining the future of non-invasive therapeutics.

Our team combines leading physicians and researchers specializing in obesity, and R&D and Medtech executives with a proven track record.

What sets us apart is our commitment to interdisciplinary development, scientific rigor, and a vision for non-invasive, drug-free healthcare solutions.

The R&D and executive teams have collaborated successfully for over four years, previously developing and advancing other Medtech innovations.

MEET THE PEOPLE
DENNIS DEROFE

HEAD OF OPERATIONS

ENGIN FRAYMAN

CHIEF EXECUTION OFFICER

LALE APAYDIN, MD

MEDICAL COMMUNICATIONS

IŞILAY KAVADARLI, MD

ANIMAL TRIALS COORDINATOR

THE PROJECTS

A radically new approach to obesity treatment.
Our patent-pending innovation leverages established medical applications, now being adapted for the treatment of obesity.

Obesity is a growing global epidemic, with over 1 billion people affected worldwide according to the World Obesity Federation, contributing significantly to healthcare burdens and chronic disease rates. It is now associated with more than 230 comorbid conditions, including type 2 diabetes, cardiovascular disease, and certain cancers (Yuen et al., 2016). Despite the severity of its health implications, existing treatment options remain limited and often inadequate. Lifestyle interventions such as diet and exercise frequently fail to produce sustained results. Pharmacological treatments, while expanding, are costly and often come with side effects and adherence challenges (Morgan Stanley, 2024). Bariatric surgery, though effective in achieving significant weight loss, is invasive, costly, and underutilized due to surgical risks, accessibility issues, and social stigma (Telem et al., 2024; Murtha et al., 2021). These limitations highlight an urgent need for safer, more accessible, and patient-friendly therapeutic alternatives.

Our innovation is built on a proprietary platform design to safely support appetite regulation and promote effective weight loss. By combining personalized care with breakthrough science, we aim to empower individuals in their weight management journey with a solution that does not rely on medications or require surgery.

CONTACT US

Reach out to
learn more

Contact Us

contact@wave-effect.tech

Location

Kon. Julianalaan 10, 1st Floor, 2595 AA Den Haag, Netherlands